Annual EBIT
$8.53 B
+$538.87 M+6.74%
31 December 2023
Summary:
GSK annual earnings before interest & taxes is currently $8.53 billion, with the most recent change of +$538.87 million (+6.74%) on 31 December 2023. During the last 3 years, it has risen by +$2.53 billion (+42.13%). GSK annual EBIT is now -50.43% below its all-time high of $19.70 billion.GSK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$286.27 M
-$1.82 B-86.41%
30 September 2024
Summary:
GSK quarterly earnings before interest & taxes is currently $286.27 million, with the most recent change of -$1.82 billion (-86.41%) on 30 September 2024. Over the past year, it has dropped by -$376.94 million (-56.84%). GSK quarterly EBIT is now -98.13% below its all-time high of $15.33 billion, reached on 31 March 2015.GSK Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$4.98 B
-$2.21 B-30.74%
30 September 2024
Summary:
GSK TTM earnings before interest & taxes is currently $4.98 billion, with the most recent change of -$2.21 billion (-30.74%) on 30 September 2024. Over the past year, it has dropped by -$3.46 billion (-40.98%). GSK TTM EBIT is now -74.57% below its all-time high of $19.60 billion, reached on 31 March 2015.GSK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -56.8% | -41.0% |
| 3 y3 years | +42.1% | -56.2% | -25.6% |
| 5 y5 years | -5.9% | -88.2% | -44.9% |
GSK EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +42.1% | -90.7% | at low | -49.9% | at low |
| 5 y | 5 years | -5.9% | +42.1% | -92.0% | +127.7% | -56.0% | at low |
| alltime | all time | -50.4% | -98.1% | +103.2% | -74.6% | >+9999.0% |
GSK EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $286.27 M(-86.4%) | $4.98 B(-30.7%) |
| June 2024 | - | $2.11 B(+9.2%) | $7.20 B(-7.8%) |
| Mar 2024 | - | $1.93 B(+190.9%) | $7.81 B(-7.5%) |
| Dec 2023 | $8.53 B(+6.7%) | $663.21 M(-73.5%) | $8.44 B(-15.1%) |
| Sept 2023 | - | $2.50 B(-8.1%) | $9.95 B(+12.1%) |
| June 2023 | - | $2.72 B(+6.0%) | $8.88 B(+17.7%) |
| Mar 2023 | - | $2.56 B(+18.3%) | $7.54 B(-6.4%) |
| Dec 2022 | $7.99 B(+33.2%) | $2.17 B(+51.9%) | $8.06 B(+23.1%) |
| Sept 2022 | - | $1.43 B(+3.1%) | $6.55 B(-6.9%) |
| June 2022 | - | $1.38 B(-55.2%) | $7.03 B(-5.1%) |
| Mar 2022 | - | $3.08 B(+371.8%) | $7.41 B(+10.7%) |
| Dec 2021 | $6.00 B(-22.3%) | $653.80 M(-65.8%) | $6.70 B(+33.7%) |
| Sept 2021 | - | $1.91 B(+8.7%) | $5.01 B(-9.1%) |
| June 2021 | - | $1.76 B(-25.7%) | $5.51 B(-24.6%) |
| Mar 2021 | - | $2.37 B(-329.4%) | $7.31 B(-3.6%) |
| Dec 2020 | $7.72 B(-14.8%) | -$1.03 B(-142.8%) | $7.59 B(-31.3%) |
| Sept 2020 | - | $2.42 B(-32.1%) | $11.05 B(-2.6%) |
| June 2020 | - | $3.56 B(+34.5%) | $11.34 B(+16.8%) |
| Mar 2020 | - | $2.65 B(+9.0%) | $9.71 B(+7.4%) |
| Dec 2019 | $9.07 B(+23.7%) | $2.43 B(-10.3%) | $9.04 B(+6.2%) |
| Sept 2019 | - | $2.71 B(+40.3%) | $8.52 B(+2.2%) |
| June 2019 | - | $1.93 B(-2.5%) | $8.34 B(+11.0%) |
| Mar 2019 | - | $1.98 B(+4.0%) | $7.51 B(+2.9%) |
| Dec 2018 | $7.33 B(+33.2%) | $1.90 B(-24.6%) | $7.29 B(+17.9%) |
| Sept 2018 | - | $2.52 B(+129.3%) | $6.19 B(+0.5%) |
| June 2018 | - | $1.10 B(-37.6%) | $6.15 B(+21.4%) |
| Mar 2018 | - | $1.76 B(+121.8%) | $5.07 B(-7.2%) |
| Dec 2017 | $5.50 B(+52.9%) | $795.42 M(-68.1%) | $5.47 B(+1.0%) |
| Sept 2017 | - | $2.49 B(>+9900.0%) | $5.41 B(+12.1%) |
| June 2017 | - | $17.90 M(-99.2%) | $4.83 B(+4.6%) |
| Mar 2017 | - | $2.16 B(+191.3%) | $4.62 B(+31.3%) |
| Dec 2016 | $3.60 B(-79.1%) | $741.57 M(-61.1%) | $3.52 B(+45.8%) |
| Sept 2016 | - | $1.91 B(-1084.2%) | $2.41 B(+14.0%) |
| June 2016 | - | -$193.92 M(-118.3%) | $2.12 B(-25.5%) |
| Mar 2016 | - | $1.06 B(-392.6%) | $2.84 B(-83.4%) |
| Dec 2015 | $17.21 B(+184.4%) | -$362.52 M(-122.5%) | $17.11 B(-7.9%) |
| Sept 2015 | - | $1.61 B(+204.1%) | $18.57 B(+2.2%) |
| June 2015 | - | $529.98 M(-96.5%) | $18.18 B(-7.3%) |
| Mar 2015 | - | $15.33 B(+1292.3%) | $19.60 B(+223.1%) |
| Dec 2014 | $6.05 B(-47.6%) | $1.10 B(-9.3%) | $6.07 B(-35.0%) |
| Sept 2014 | - | $1.21 B(-38.0%) | $9.33 B(-11.9%) |
| June 2014 | - | $1.96 B(+9.0%) | $10.58 B(-3.0%) |
| Mar 2014 | - | $1.80 B(-58.8%) | $10.91 B(-6.1%) |
| Dec 2013 | $11.56 B(-0.9%) | $4.36 B(+76.6%) | $11.62 B(+12.7%) |
| Sept 2013 | - | $2.47 B(+8.3%) | $10.31 B(-1.8%) |
| June 2013 | - | $2.28 B(-9.0%) | $10.50 B(-4.0%) |
| Mar 2013 | - | $2.51 B(-18.0%) | $10.95 B(-6.1%) |
| Dec 2012 | $11.66 B(-14.0%) | $3.06 B(+14.9%) | $11.66 B(+1.1%) |
| Sept 2012 | - | $2.66 B(-2.3%) | $11.53 B(-6.3%) |
| June 2012 | - | $2.72 B(-15.5%) | $12.30 B(-1.7%) |
| Mar 2012 | - | $3.22 B(+10.2%) | $12.52 B(-7.6%) |
| Dec 2011 | $13.56 B(+123.1%) | $2.93 B(-14.8%) | $13.56 B(+33.1%) |
| Sept 2011 | - | $3.43 B(+16.7%) | $10.19 B(+3.5%) |
| June 2011 | - | $2.94 B(-30.9%) | $9.84 B(+39.8%) |
| Mar 2011 | - | $4.26 B(-1055.5%) | $7.04 B(+15.1%) |
| Dec 2010 | $6.08 B(-55.3%) | -$445.46 M(-114.4%) | $6.11 B(-42.2%) |
| Sept 2010 | - | $3.09 B(+2154.6%) | $10.58 B(-3.4%) |
| June 2010 | - | $137.14 M(-95.9%) | $10.96 B(-23.3%) |
| Mar 2010 | - | $3.33 B(-17.2%) | $14.28 B(+4.7%) |
| Dec 2009 | $13.59 B(-2.1%) | $4.02 B(+16.1%) | $13.64 B(+12.0%) |
| Sept 2009 | - | $3.46 B(-0.0%) | $12.18 B(+1.0%) |
| June 2009 | - | $3.46 B(+29.0%) | $12.06 B(-4.6%) |
| Mar 2009 | - | $2.69 B(+4.9%) | $12.64 B(-9.7%) |
| Dec 2008 | $13.87 B(-15.5%) | $2.56 B(-23.5%) | $13.99 B(-12.1%) |
| Sept 2008 | - | $3.35 B(-17.2%) | $15.92 B(+25.6%) |
| June 2008 | - | $4.04 B(+0.0%) | $12.68 B(+0.3%) |
| Mar 2008 | - | $4.04 B(-9.9%) | $12.64 B(-2.6%) |
| Dec 2007 | $16.41 B(+14.0%) | $4.49 B(+4185.0%) | $12.97 B(+15.2%) |
| Sept 2007 | - | $104.74 M(-97.4%) | $11.27 B(-26.9%) |
| June 2007 | - | $4.01 B(-8.5%) | $15.42 B(+3.4%) |
| Mar 2007 | - | $4.38 B(+57.4%) | $14.91 B(+4.0%) |
| Dec 2006 | $14.39 B(+2074.0%) | $2.78 B(-34.6%) | $14.34 B(+438.2%) |
| Sept 2006 | - | $4.25 B(+21.7%) | $2.66 B(+34.6%) |
| June 2006 | - | $3.50 B(-8.2%) | $1.98 B(+19.7%) |
| Mar 2006 | - | $3.81 B(-142.8%) | $1.65 B(+40.7%) |
| Dec 2005 | $661.92 M(-93.7%) | -$8.89 B(-349.1%) | $1.17 B(-90.5%) |
| Sept 2005 | - | $3.57 B(+12.6%) | $12.38 B(+7.3%) |
| June 2005 | - | $3.17 B(-4.7%) | $11.53 B(+1.1%) |
| Mar 2005 | - | $3.33 B(+44.0%) | $11.40 B(+5.2%) |
| Dec 2004 | $10.54 B | $2.31 B(-15.2%) | $10.84 B(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2004 | - | $2.72 B(-10.4%) | $10.36 B(+0.0%) |
| June 2004 | - | $3.04 B(+9.8%) | $10.36 B(-0.7%) |
| Mar 2004 | - | $2.77 B(+51.4%) | $10.43 B(+0.4%) |
| Dec 2003 | $10.44 B(+21.6%) | $1.83 B(-32.8%) | $10.39 B(-3.9%) |
| Sept 2003 | - | $2.72 B(-12.7%) | $10.82 B(+9.5%) |
| June 2003 | - | $3.12 B(+14.3%) | $9.88 B(+7.5%) |
| Mar 2003 | - | $2.72 B(+20.9%) | $9.19 B(+7.4%) |
| Dec 2002 | $8.58 B(-2.4%) | $2.25 B(+26.3%) | $8.56 B(-17.8%) |
| Sept 2002 | - | $1.78 B(-26.6%) | $10.42 B(+7.8%) |
| June 2002 | - | $2.43 B(+16.4%) | $9.66 B(+3.6%) |
| Mar 2002 | - | $2.09 B(-49.2%) | $9.32 B(+6.1%) |
| Dec 2001 | $8.79 B(-8.6%) | $4.11 B(+299.0%) | $8.79 B(+1.7%) |
| Sept 2001 | - | $1.03 B(-50.7%) | $8.64 B(-6.8%) |
| June 2001 | - | $2.09 B(+34.9%) | $9.27 B(+0.9%) |
| Mar 2001 | - | $1.55 B(-60.9%) | $9.18 B(-3.5%) |
| Dec 2000 | $9.62 B(+113.7%) | $3.97 B(+138.9%) | $9.52 B(<-9900.0%) |
| Sept 2000 | - | $1.66 B(-17.2%) | -$41.95 M(-102.2%) |
| June 2000 | - | $2.00 B(+6.4%) | $1.94 B(+88.5%) |
| Mar 2000 | - | $1.88 B(-133.7%) | $1.03 B(-57.6%) |
| Dec 1999 | $4.50 B(-5.5%) | -$5.59 B(-253.4%) | $2.43 B(-16.7%) |
| Sept 1999 | - | $3.65 B(+233.8%) | $2.92 B(+9.2%) |
| June 1999 | - | $1.09 B(-66.8%) | $2.67 B(+3.1%) |
| Mar 1999 | - | $3.29 B(-164.4%) | $2.59 B(+4.3%) |
| Dec 1998 | $4.76 B(-0.2%) | -$5.11 B(-250.1%) | $2.49 B(+11.3%) |
| Sept 1998 | - | $3.40 B(+236.4%) | $2.23 B(+7.0%) |
| June 1998 | - | $1.01 B(-68.2%) | $2.09 B(-52.2%) |
| Mar 1998 | - | $3.18 B(-159.3%) | $4.37 B(-3.5%) |
| Dec 1997 | $4.77 B(-5.7%) | -$5.36 B(-264.7%) | $4.53 B(-35.7%) |
| Sept 1997 | - | $3.25 B(-1.1%) | $7.04 B(-8.0%) |
| June 1997 | - | $3.29 B(-1.4%) | $7.65 B(+1.4%) |
| Mar 1997 | - | $3.34 B(-217.3%) | $7.55 B(+1.1%) |
| Dec 1996 | $5.06 B(+17.7%) | -$2.85 B(-173.6%) | $7.47 B(-27.6%) |
| Sept 1996 | - | $3.87 B(+21.3%) | $10.31 B(+14.5%) |
| June 1996 | - | $3.19 B(-2.1%) | $9.01 B(+1745.6%) |
| Mar 1996 | - | $3.26 B(+27.0%) | $488.17 M(-79.4%) |
| Dec 1995 | $4.30 B(+87.4%) | - | - |
| Sept 1995 | - | $2.56 B(-148.1%) | $2.37 B(+1.4%) |
| June 1995 | - | -$5.33 B(-310.9%) | $2.34 B(-41.0%) |
| June 1995 | $2.29 B(-18.4%) | - | - |
| Mar 1995 | - | $2.53 B(-3.3%) | $3.97 B(+7.2%) |
| Dec 1994 | - | $2.61 B(+3.3%) | $3.70 B(+15.4%) |
| Sept 1994 | - | $2.53 B(-168.3%) | $3.21 B(+15.8%) |
| June 1994 | $2.81 B(-0.0%) | -$3.71 B(-263.9%) | $2.77 B(-14.6%) |
| Mar 1994 | - | $2.26 B(+6.6%) | $3.24 B(+1.0%) |
| Dec 1993 | - | $2.12 B(+1.3%) | $3.21 B(+10.8%) |
| Sept 1993 | - | $2.09 B(-164.8%) | $2.90 B(+8.7%) |
| June 1993 | $2.81 B(+7.3%) | -$3.23 B(-245.0%) | $2.66 B(+5.8%) |
| Mar 1993 | - | $2.23 B(+23.3%) | $2.52 B(+10.9%) |
| Dec 1992 | - | $1.81 B(-2.9%) | $2.27 B(-1.8%) |
| Sept 1992 | - | $1.86 B(-155.1%) | $2.31 B(-0.5%) |
| June 1992 | $2.62 B(+4.0%) | -$3.38 B(-270.5%) | $2.33 B(-41.3%) |
| Mar 1992 | - | $1.98 B(+7.2%) | $3.96 B(+13.4%) |
| Dec 1991 | - | $1.85 B(-1.3%) | $3.49 B(+15.1%) |
| Sept 1991 | - | $1.87 B(-207.3%) | $3.03 B(+19.9%) |
| June 1991 | $2.52 B(+26.3%) | -$1.75 B(-215.4%) | $2.53 B(-0.9%) |
| Mar 1991 | - | $1.51 B(+8.7%) | $2.55 B(+9.2%) |
| Dec 1990 | - | $1.39 B(+1.5%) | $2.34 B(+9.3%) |
| Sept 1990 | - | $1.37 B(-179.5%) | $2.14 B(+9.4%) |
| June 1990 | $2.00 B(+12.7%) | -$1.72 B(-232.7%) | $1.96 B(-20.5%) |
| Mar 1990 | - | $1.30 B(+8.8%) | $2.46 B(+12.8%) |
| Dec 1989 | - | $1.19 B(+0.5%) | $2.18 B(+9.3%) |
| Sept 1989 | - | $1.19 B(-197.3%) | $1.99 B(+9.3%) |
| June 1989 | $1.77 B(+18.4%) | -$1.22 B(-219.8%) | $1.82 B(-9.2%) |
| Mar 1989 | - | $1.02 B(+1.1%) | $2.01 B(+8.3%) |
| Dec 1988 | - | $1.01 B(-1.1%) | $1.85 B(+11.6%) |
| Sept 1988 | - | $1.02 B(-198.4%) | $1.66 B(+10.4%) |
| June 1988 | $1.50 B(+29.6%) | -$1.03 B(-219.8%) | $1.51 B(-10.5%) |
| Mar 1988 | - | $863.72 M(+6.1%) | $1.68 B(+9.7%) |
| Dec 1987 | - | $814.42 M(-5.5%) | $1.53 B(+13.5%) |
| Sept 1987 | - | $862.23 M(-200.4%) | $1.35 B(+16.3%) |
| June 1987 | $1.15 B(+29.5%) | -$858.44 M(-220.2%) | $1.16 B(-7.3%) |
| Mar 1987 | - | $714.30 M(+12.9%) | $1.25 B(+15.9%) |
| Dec 1986 | - | $632.59 M(-6.0%) | $1.08 B(+8.4%) |
| Sept 1986 | - | $672.76 M(-187.7%) | $995.94 M(+15.3%) |
| June 1986 | $891.48 M(>+9900.0%) | -$767.31 M(-241.6%) | $863.62 M(-47.0%) |
| Mar 1986 | - | $542.04 M(-1.2%) | $1.63 B(+49.8%) |
| Dec 1985 | - | $548.45 M(+1.5%) | $1.09 B(+101.5%) |
| Sept 1985 | - | $540.44 M | $540.44 M |
| June 1985 | $0.00(0.0%) | - | - |
| June 1984 | $0.00 | - | - |
FAQ
- What is GSK annual earnings before interest & taxes?
- What is the all time high annual EBIT for GSK?
- What is GSK quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for GSK?
- What is GSK quarterly EBIT year-on-year change?
- What is GSK TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for GSK?
- What is GSK TTM EBIT year-on-year change?
What is GSK annual earnings before interest & taxes?
The current annual EBIT of GSK is $8.53 B
What is the all time high annual EBIT for GSK?
GSK all-time high annual earnings before interest & taxes is $19.70 B
What is GSK quarterly earnings before interest & taxes?
The current quarterly EBIT of GSK is $286.27 M
What is the all time high quarterly EBIT for GSK?
GSK all-time high quarterly earnings before interest & taxes is $15.33 B
What is GSK quarterly EBIT year-on-year change?
Over the past year, GSK quarterly earnings before interest & taxes has changed by -$376.94 M (-56.84%)
What is GSK TTM earnings before interest & taxes?
The current TTM EBIT of GSK is $4.98 B
What is the all time high TTM EBIT for GSK?
GSK all-time high TTM earnings before interest & taxes is $19.60 B
What is GSK TTM EBIT year-on-year change?
Over the past year, GSK TTM earnings before interest & taxes has changed by -$3.46 B (-40.98%)